Leonardino (Dino) Digma retweeted
A #Stanford_Medicine neurologist explains why a trio of closely related drugs all aimed at treating #Alzheimers_disease -- while so promising in theory --don’t appear to be helping patients much if at all. #plaque_attack_fail
scopeblog.stanford.edu/2024/…
Thank you @brucegoldman for highlighting and nicely summarizing our recent commentary on the limitations of recent anti-amyloid trials.
scopeblog.stanford.edu/2024/…
Leonardino (Dino) Digma retweeted
If you’re at #ADPD2024 and curious about how Amantadine works in PD, please stop by either today or tomorrow at poster 454. Great meeting so far in Lisbon! – at Lisbon, Portugal
Leonardino (Dino) Digma retweeted
Dr. Cory Dodson @cocodods @Stanford_Neuro presents infection risk of CD20+ therapy @ACTRIMS – at West Palm Beach, FL
Another month of wards in the books! Feeling grateful to have gotten to work with the best senior (@EmilyLChu) best co-intern (@XC_Cortez) and best med student (@MedMusicMel) @StanfordMedRes
Leonardino (Dino) Digma retweeted
Great piece in @journal_ad from @leonardinosaur @joe__winer and Michael Greicius from Stanford on functional unblinding, amyloid removal as a surrogate, and data transparency.
Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies
pubmed.ncbi.nlm.nih.gov/3825…
Our commentary on some of the yet unaddressed limitations of the recent anti-amyloid therapies/trials is now out in @journal_ad !! #EndAlz #Alzheimers #ADRD #amyloid #tau #HAI2024
content.iospress.com/article…
2
237
S/p ten (10) day stretch to cap off another month on the @StanfordMedRes wards. Tough to be away from friends/fam over the holidays, but ‘twas nice working with and getting to know my future @Stanford_Neuro co-res Akshara!
17
479
Leonardino (Dino) Digma retweeted
My newest project with @PaLab_UCSD exploring the role of cerebrovascular reactivity in developing mild cognitive impairment is now out in @alzdemjournals!🧠alz-journals.onlinelibrary.w…
Leonardino (Dino) Digma retweeted
An interesting and relevant piece worth reading, by my postdoc mentor Mike Greicius: "Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies"
arxiv.org/ftp/arxiv/papers/2…
Leonardino (Dino) Digma retweeted
Is it possible to cure #AlzheimersDisease? The press has been so enthusiastic about anti-amyloid antibodies, but are they really improving patients? In this @arxiv lead by my P.I. Michael Greicius, some doubts still remain. 👉 arxiv.org/ftp/arxiv/papers/2… @StanfordMed @Stanford_Neuro
Leonardino (Dino) Digma retweeted
Check out Dino's (@leonardinosaur) excellent and important new piece on anti-amyloid therapies, written with Mike Greicius
With #CTAD23 happening, it is an exciting week for the AD field. To contribute to the discussion, we (I, @joe__winer, and Mike Greicius) wanted to highlight three observations regarding recent anti-amyloid clinical trials:
arxiv.org/abs/2310.15456
Leonardino (Dino) Digma retweeted
Wow! Some very contentious statements therein. Worth a read!
With #CTAD23 happening, it is an exciting week for the AD field. To contribute to the discussion, we (I, @joe__winer, and Mike Greicius) wanted to highlight three observations regarding recent anti-amyloid clinical trials:
arxiv.org/abs/2310.15456
With #CTAD23 happening, it is an exciting week for the AD field. To contribute to the discussion, we (I, @joe__winer, and Mike Greicius) wanted to highlight three observations regarding recent anti-amyloid clinical trials:
arxiv.org/abs/2310.15456
Sad that I can’t be in Amsterdam for #AAIC23 but excited to share our work as a virtual poster for the conference. This project involved a post-hoc analysis of the EXERT trial, looking at the association between amount of exercise completed and regional brain atrophy.
Looking forward to digging into these associations further. Feel free to reach out if you have any questions or want a higher resolution version of the poster.
1
1
183
















